MIRM Q2 2022 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

MIRMMirum Pharmaceuticals, Inc.

$5B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M+58.9% YoY

Gross Profit

$15M85.6% margin

Operating Income

-$31M-179.8% margin

Net Income

-$27M-154.0% margin

EPS (Diluted)

$-0.84

QoQ Revenue Growth

+35.6%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$297M

Total Liabilities

$187M

Stockholders' Equity

$111M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$11M	+58.9%
Gross Profit	$15M	$11M	+36.0%
Operating Income	-$31M	-$37M	+15.9%
Net Income	-$27M	-$44M	+38.7%

Revenue Segments

Product

$17M100%